Abstract
Endometrial stromal sarcoma (ESS) is a rare neoplasm, mainly observed in premenopausal women. We describe two women 44 and 34 years old at the time ESS diagnosis, who developed lung metastases 3 and 6 years, respectively, after initial treatment: hysterectomy without (case 1) or with oophorectomy (case 2), followed by hormone replacement therapy (HRT) for the latter. Their estrogen (ER) and progesterone receptors (PR) were analyzed biochemically in metastatic lung tissue, yielding respective concentrations of ER 242 and 184, and PR 910 and 100 fmol/mg of cytosol protein. Both patients started treatment with the aromatase inhibitor aminoglutethimide (500 mg qid) after surgery for the first patient and after stopping HRT for the second. Under aromatase-inhibitor therapy, both patients achieved a complete response, patient 1 remains disease-free with 14+ years of follow-up, and patient 2 with 7+ years. Our data suggest that an aromatase inhibitor may be an effective treatment for ESS. Furthermore, routine ER and PR analyses could be useful to predict the response to hormonal therapy in ESS.
Similar content being viewed by others
References
Boutselis, J.G. and Ullery, J.C. (1962). Sarcomas of the uterus. Obstet Gynecol 20:23–35.
Yoonessi, M. and Hart, W.R. (1977) Endometrial stromal sarcomas. Cancer 40:898–906.
Koss, L.G., Spiro, R.H. and Brunschwig, A. (1965) Endometrial stromal sarcoma. Surg Gynecol Obstet 121:531–537.
Katz, L., Merino, M.J., Sakamoto, H. and Schwartz, P. (1987) Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors. Gynecol Oncol 26:87–97.
Tsukamoto, N., Kamura, T. and Mutsukuma, K. (1985) Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestins. Gynecol Oncol 20:120–128.
Scribner, D.R. and Walker, J.L. (1998) Low grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and megace. Gynecol Oncol 71(3):458–460.
Maluf, F.C., Sabbatini, P., Schwartz, L., Xia, J. and Aghajanian, C. (2001) Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82:384–388.
Stuart-Harris, R.C. and Smith, I.E. (1984) Aminoglutethimide in the treatment of advanced breast cancer. Cancer Treat Rev 11:189–204.
Buzdar, A. and Howell, A. (2001) Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Research 7:2620–2635.
Doran, A.H.G. and Lockyer, C. (1908) Two cases of uterine fibroids sharing peritheliomatous changes: long immunity from recurrence after operation. Proc R Soc Med 25:2.
Hart, W.R. and Yoonessi, M. (1977) Endometrial stromatosis of the uterus, Obstet Gynecol 49:393–403.
Kerby, I.J. (1975) Stromal endometriosis. Clin Radiol 26:99–101.
Barlesi, F., et al. (2001) Multiple pulmonary leiomyomatous nodules: benign metastasizing leiomyoma? Rev Mal Respir 18:440–442.
Jautzke, G., Muller-Ruchholtz, E. and Thalmann, U. (1996) Immunohistological detection of estrogen and progesterone receptors in multiple and well-differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas). A report on 5 cases. Pathol Res Pract 192:215–223.
Canzonieri, V., et al. (1994) Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis. Virschows Arch 425:541–545.
McCluggage, W.G., Bailie, C., Weir, P. and Bharucha, H. (1996) Endometrial stromal sarcoma arising in pelvic endometriosis in a patient receiving unopposed oestrogen therapy. Br J Obstet Gynaecol 103:1252–1254.
Ursic-Vrscaj, M. (1999) Hormone replacement therapy after uterine leiomyosarcoma treatment. Case reports. Eur J Gynaecal Oncol 20:379–382.
Pellilo, D. (1968) Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a long-acting synthetic progestin: a case report. Obstet Gynecol 49:393–403.
Tseng, L., et al. (1986) Endocrine aspects of human uterine sarcoma: a preliminary study. Am J Obstet Gynecol 155:95–101.
Schwartz, P.E. (1983) Steroid-receptor proteins in nonepithelial malignancies of the ovary. Gynecol Oncol 15:305–315.
Dowbernowsky, P., Smith, I. and Falkson, G. (1998) Letrozole (Femara), a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol 16:453–461.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spano, J.P., Soria, J.C., Kambouchner, M. et al. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 20, 87–93 (2003). https://doi.org/10.1385/MO:20:1:87
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:20:1:87